CN Patent

CN105658211A — 左旋多巴和/或左旋多巴的酯的粘膜粘附性、控制释放调配物和其用途

Assigned to Impax Laboratories LLC · Expires 2016-06-08 · 10y expired

What this patent protects

本发明提供一种控制释放经口固体调配物，其包含(a)包含含左旋多巴和/或左旋多巴的酯或其盐的核心的控制释放组分，其中所述核心涂布有粘膜粘附性聚合物的层且外部涂布有包覆肠溶涂层的聚合物的层；和(b)脱羧酶抑制剂组分。

USPTO Abstract

本发明提供一种控制释放经口固体调配物，其包含(a)包含含左旋多巴和/或左旋多巴的酯或其盐的核心的控制释放组分，其中所述核心涂布有粘膜粘附性聚合物的层且外部涂布有包覆肠溶涂层的聚合物的层；和(b)脱羧酶抑制剂组分。

Drugs covered by this patent

Patent Metadata

Patent number
CN105658211A
Jurisdiction
CN
Classification
—
Expires
2016-06-08
Drug substance claim
No
Drug product claim
No
Assignee
Impax Laboratories LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.